0000899243-20-025431.txt : 20200916
0000899243-20-025431.hdr.sgml : 20200916
20200916204033
ACCESSION NUMBER: 0000899243-20-025431
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200916
FILED AS OF DATE: 20200916
DATE AS OF CHANGE: 20200916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VV Manager II, LLC
CENTRAL INDEX KEY: 0001824569
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 201179907
BUSINESS ADDRESS:
STREET 1: 40 BROAD STREET
STREET 2: SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 6176489100
MAIL ADDRESS:
STREET 1: 40 BROAD STREET
STREET 2: SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vida Ventures II, LLC
CENTRAL INDEX KEY: 0001776851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 201179908
BUSINESS ADDRESS:
STREET 1: 40 BROAD STREET, SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-254-9492
MAIL ADDRESS:
STREET 1: 40 BROAD STREET, SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VIDA VENTURES II-A, LLC
CENTRAL INDEX KEY: 0001781930
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 201179909
BUSINESS ADDRESS:
STREET 1: 40 BROAD STREET, SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-254-9492
MAIL ADDRESS:
STREET 1: 40 BROAD STREET, SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-09-16
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001824569
VV Manager II, LLC
40 BROAD STREET, SUITE 201
BOSTON
MA
02109
0
0
1
0
0001776851
Vida Ventures II, LLC
40 BROAD STREET, SUITE 201
BOSTON
MA
02109
0
0
1
0
0001781930
VIDA VENTURES II-A, LLC
40 BROAD STREET, SUITE 201
BOSTON
MA
02109
0
0
1
0
Series B Preferred Stock
Common Stock
2087130
I
See footnote
Series B Preferred Stock
Common Stock
57916
I
See footnote
The Series B Preferred Stock is convertible into common stock on a 3.3169-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
The shares are held directly by Vida Ventures II, LLC ("Vida II"). VV Manager II, LLC ("VV Manager II") is the manager of Vida II. Arie Belldegrun, Fred Cohen, and Leonard Potter are the members of the management committee of VV Manager II (the "Management Committee") and Stefan Vitorovic, Arjun Goyal, Helen Kim, Rajul Jain, and Joshua Kazam are the members of the investment committee of VV Manager II (the "Investment Committee").
(Continued from footnote 2) Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.
The shares are held directly by Vida Ventures II-A, LLC ("Vida II-A"). VV Manager II is the manager of Vida II-A. Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II-A. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II-A and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.
/s/ Vida Ventures II, LLC By: VV Manager II, LLC, its Manager, By: /s/ Stefan Vitorovic, its Managing Director
2020-09-16
/s/ Vida Ventures II-A, LLC By: VV Manager II, LLC, its Manager, By: /s/ Stefan Vitorovic, its Managing Director
2020-09-16
/s/ VV Manager II, LLC, By: /s/ Stefan Vitorovic, its Managing Director
2020-09-16